Tudor Investment Corp
ATRA icon

Tudor Investment Corp’s Atara Biotherapeutics ATRA Stock Holding History

Tudor Investment Corp’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,331
Closed -$601K – 2391
2022
Q4 		$601K Sell
7,331
-1,494
-17% -$156K 0.01% 1461
2022
Q3 		$834K Buy
8,825
+5,304
+151% +$596K 0.02% 1044
2022
Q2 		$686K Buy
3,521
+1,599
+83% +$261K 0.02% 1097
2022
Q1 		$446K Buy
+1,922
New +$612K 0.01% 1332
2021
Q1 		– Sell
-564
Closed -$277K – 1551
2020
Q4 		$277K Sell
564
-149
-21% -$68.8K 0.01% 1142
2020
Q3 		$231K Buy
+713
New +$243K 0.01% 1092
2020
Q2 		– Sell
-3,039
Closed -$646K – 1165
2020
Q1 		$646K Buy
3,039
+1,269
+72% +$403K 0.06% 388
2019
Q4 		$729K Buy
+1,770
New +$610K 0.03% 603
2016
Q1 		– Sell
-764
Closed -$504K – 1728
2015
Q4 		$504K Buy
+764
New +$578K 0.01% 869

Other funds holding ATRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return